Boston Scientific
437 hedge funds and large institutions have $14.1B invested in Boston Scientific in 2014 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 128 increasing their positions, 192 reducing their positions, and 54 closing their positions.
168% more call options, than puts
Call options by funds: $61.5M | Put options by funds: $22.9M
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
0.51% less ownership
Funds ownership: 90.68% → 90.17% (-0.51%)
5% less funds holding
Funds holding: 458 → 437 (-21)
8% less capital invested
Capital invested by funds: $15.3B → $14.1B (-$1.2B)
31% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 54
33% less repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 192
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$284M |
| 2 |
JP Morgan Chase
New York
|
+$246M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$120M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$89.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$45.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$230M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$171M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$128M |
| 4 |
CCI
Columbus Circle Investors
|
-$124M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$103M |
BSX Hedge Fund Activity: Q3 2014 in Review
437 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2014, worth a combined $14.1B — down 7.8% from $15.3B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of BSX and 37 opened new positions — a net loss of 17 holders — while 192 trimmed existing stakes and 128 added.
The largest buyer was Fidelity Investments, adding an estimated $284M. The largest seller was Capital Research Global Investors, cutting an estimated $230M.
- 437 institutional investors held Boston Scientific (BSX) as of Q3 2014, down from 458 in Q2 2014.
- Funds reported $14.1B of Boston Scientific stock for Q3 2014, down 7.8% quarter-over-quarter.
- 37 funds opened new Boston Scientific positions in Q3 2014 and 54 closed out, a net change of -17 holders.
- The largest Boston Scientific buyer in Q3 2014 was Fidelity Investments, an estimated $284M added.
- The largest Boston Scientific seller in Q3 2014 was Capital Research Global Investors, an estimated $230M sold.
Based on aggregated 13F filings for Q3 2014.